Your browser doesn't support javascript.
loading
Absorption, elimination and cerebrospinal fluid concentrations of nimodipine in healthy beagle dogs receiving human intravenous and oral formulation.
Koskimäki, Janne; Tarkia, Miikka; Ahtola-Sätilä, Tuula; Saloranta, Lasse; Laakso, Aki; Frantzén, Janek.
Afiliação
  • Koskimäki J; Faculty of Medicine, University of Turku, Kiinamyllynkatu 4-8, P.O. Box 52, 20520, Turku, Finland.
  • Tarkia M; Department of Neurosurgery, Helsinki University Central Hospital, Topeliuksenkatu 5, P.O. Box 266, 00029, Helsinki, Finland.
  • Ahtola-Sätilä T; Turku PET Centre, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-8, P.O Box 52, 20521, Turku, Finland.
  • Saloranta L; Chemistry and Safety Sciences, R&D, Orion Corporation, Orion Pharma, Orionintie 1A, P.O. Box 65, 02101, Espoo, Finland.
  • Laakso A; Chemistry and Safety Sciences, R&D, Orion Corporation, Orion Pharma, Orionintie 1A, P.O. Box 65, 02101, Espoo, Finland.
  • Frantzén J; Department of Neurosurgery, Helsinki University Central Hospital, Topeliuksenkatu 5, P.O. Box 266, 00029, Helsinki, Finland.
Eur J Drug Metab Pharmacokinet ; 41(3): 295-300, 2016 Jun.
Article em En | MEDLINE | ID: mdl-25652785
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nimodipina / Líquido Cefalorraquidiano Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nimodipina / Líquido Cefalorraquidiano Idioma: En Ano de publicação: 2016 Tipo de documento: Article